Bruton's Tyrosine Kinase Inhibitors

Name

Bruton's Tyrosine Kinase Inhibitors

Accession Number

DBCAT005514

Description

Not Available

Drugs

Drug	Drug Description
Zanubrutinib	A kinase inhibitor used to treat mantle cell lymphoma, a type of B-cell non-Hodgkin lymphoma, in adults who previously received therapy.

Drugs & Drug Targets

Drug	Target	Type
Zanubrutinib	Cytochrome P450 3A4	enzyme
Zanubrutinib	P-glycoprotein 1	transporter
Zanubrutinib	Cytochrome P450 2B6	enzyme
Zanubrutinib	Tyrosine-protein kinase BTK	target
Zanubrutinib	Epidermal growth factor receptor	target
Zanubrutinib	Receptor tyrosine-protein kinase erbB-2	target
Zanubrutinib	Receptor tyrosine-protein kinase erbB-4	target
Zanubrutinib	Tyrosine-protein kinase ITK/TSK	target
Zanubrutinib	Cytoplasmic tyrosine-protein kinase BMX	target
Zanubrutinib	Tyrosine-protein kinase JAK2	target
Zanubrutinib	Tyrosine-protein kinase Tec	target
Zanubrutinib	Tyrosine-protein kinase Blk	target
Zanubrutinib	Tyrosine-protein kinase JAK3	target
Zanubrutinib	Protein-tyrosine kinase 6	target
Zanubrutinib	Tyrosine-protein kinase Fgr	target
Zanubrutinib	Tyrosine-protein kinase FRK	target
Zanubrutinib	Tyrosine-protein kinase Lck	target
Zanubrutinib	Tyrosine-protein kinase TXK	target
Zanubrutinib	Cytochrome P450 3A Subfamily	enzyme